ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,479, issued on July 15, was assigned to RIVERMARK MEDICAL INC. (Milwaukee).
"Intraluminal stent with handle for treating benign prostatic hyperplasia" was invented by Adam Kadlec (Milwaukee), Anand Doraiswamy (Oakland, Calif.), Andrew Schieber (North Tustin, Calif.), Marcus Souza (Costa Mesa, Calif.) and Nathan Chu (Irvine, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A stent is disclosed that is configured to maintain patency of the prostatic urethra despite an enlarged prostate. The stent can include a handle that, in an undeflected position, is disposed outside of the flow path of the stent. When the handle is pulled, the handle can defl...